Lion Point Capital, LP - Q3 2020 holdings

$456 Million is the total value of Lion Point Capital, LP's 24 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 16.7% .

 Value Shares↓ Weighting
CSIQ SellCANADIAN SOLAR INC$116,792,000
+41.4%
3,327,426
-22.3%
25.62%
+27.9%
ACHC  ACADIA HEALTHCARE COMPANY IN$45,943,000
+17.4%
1,558,4720.0%10.08%
+6.1%
TGTX BuyTG THERAPEUTICS INC$35,530,000
+103.2%
1,327,734
+47.9%
7.79%
+83.7%
NewMARINUS PHARMACEUTICALS INC$34,930,0002,718,334
+100.0%
7.66%
DRRX SellDURECT CORP$30,319,000
-29.7%
17,730,680
-4.6%
6.65%
-36.4%
LBTYA  LIBERTY GLOBAL PLC$26,262,000
-3.9%
1,250,0000.0%5.76%
-13.1%
SWIR  SIERRA WIRELESS INC$23,931,000
+24.3%
2,144,3960.0%5.25%
+12.4%
ARNC  ARCONIC CORPORATION$22,264,000
+36.8%
1,168,7490.0%4.88%
+23.7%
AA  ALCOA CORP$19,752,000
+3.5%
1,698,3820.0%4.33%
-6.4%
PRSP  PERSPECTA INC$17,505,000
-16.3%
900,0000.0%3.84%
-24.3%
IWM NewISHARES TRrussell 2000 etf$13,930,00093,000
+100.0%
3.06%
LSCC BuyLATTICE SEMICONDUCTOR CORP$13,269,000
+11.8%
458,188
+9.6%
2.91%
+1.1%
BATL BuyBATTALION OIL CORP$11,344,000
-16.5%
1,435,981
+0.4%
2.49%
-24.5%
XOP  SPDR SER TRput$9,992,000
-19.4%
237,5000.0%2.19%
-27.1%
KNSA  KINIKSA PHARMACEUTICALS LTD$7,594,000
-39.9%
495,7480.0%1.67%
-45.6%
LUMO  LUMOS PHARMA INC$5,627,000
-16.2%
407,1920.0%1.23%
-24.2%
LOGC  LOGICBIO THERAPEUTICS INC$4,540,000
+7.3%
500,0000.0%1.00%
-2.9%
OUT  OUTFRONT MEDIA INC$4,365,000
+2.7%
300,0000.0%0.96%
-7.2%
SCOR  COMSCORE INC$3,921,000
-34.2%
1,922,2410.0%0.86%
-40.5%
EXTR  EXTREME NETWORKS INC$3,263,000
-7.4%
811,8350.0%0.72%
-16.2%
AGLE  AEGLEA BIOTHERAPEUTICS INC$2,127,000
-23.4%
300,0000.0%0.47%
-30.6%
OPESU  OPES ACQUISITION CORPunit 03/07/2023$1,468,000
-24.3%
83,4380.0%0.32%
-31.5%
OVV  OVINTIV INC$735,000
-14.5%
90,1080.0%0.16%
-23.0%
LBTYK  LIBERTY GLOBAL PLC$513,000
-4.5%
25,0000.0%0.11%
-13.1%
PDCE ExitPDC ENERGY INC$0-1,466,079
-100.0%
-4.42%
MRNS ExitMARINUS PHARMACEUTICALS INC$0-10,873,340
-100.0%
-6.70%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-11-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CANADIAN SOLAR INC21Q2 202125.6%
ALCOA CORP21Q1 20228.0%
ISHARES TR19Q3 202339.2%
COMSCORE INC19Q4 20225.8%
HALCON RES CORP15Q3 20233.3%
KINIKSA PHARMACEUTICALS LTD15Q3 20233.1%
LUMOS PHARMA INC15Q3 20232.8%
DURECT CORP14Q3 202210.5%
ARCONIC INC14Q1 20204.4%
MARINUS PHARMACEUTICALS INC13Q3 202311.6%

View Lion Point Capital, LP's complete holdings history.

Latest significant ownerships (13-D/G)
Lion Point Capital, LP Q3 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
SIERRA WIRELESS INCJune 07, 20221,810,6714.7%
BATTALION OIL CORPFebruary 14, 2022352,8512.2%
DURECT CORPFebruary 14, 202215,486,0046.8%
LUMOS PHARMA, INC.February 12, 2021407,1924.9%
BurgerFi International, Inc.January 11, 20212,745,93815.7%
Canadian Solar Inc.November 27, 20202,453,7244.1%
NEWLINK GENETICS CORPFebruary 14, 20203,114,7338.3%
CARRIZO OIL & GAS INCOctober 29, 20194,584,4005.0%
LATTICE SEMICONDUCTOR CORPJuly 22, 20196,467,0354.9%
Cimarex Resolute LLCMarch 05, 2019? ?

View Lion Point Capital, LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
SC 13G/A2023-02-14
SC 13G/A2023-02-14
13F-HR2022-11-14

View Lion Point Capital, LP's complete filings history.

Compare quarters

Export Lion Point Capital, LP's holdings